학술논문

Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; NOV 2022, 38 9, pS1465-pS1466, 2p. Supplement: 9
Subject
Language
English
ISSN
15698041